These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22169635)

  • 1. [Uterine smooth muscle tumors: relationship between morphology and biologic behavior].
    Hui YZ
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):505-7. PubMed ID: 22169635
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress in clinicopathologic study on uterine smooth muscle tumor of uncertain malignant potential].
    Deng ZJ; Guo LN
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):573-6. PubMed ID: 22169655
    [No Abstract]   [Full Text] [Related]  

  • 3. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
    O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
    Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors.
    Ünver NU; Acikalin MF; Öner Ü; Ciftci E; Ozalp SS; Colak E
    Arch Gynecol Obstet; 2011 Aug; 284(2):483-90. PubMed ID: 20878171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
    Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined uterine smooth muscle tumour: a challenging case.
    Viola P; Colasante A
    Pathologica; 2012 Aug; 104(4):193-7. PubMed ID: 23316624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
    Ip PP; Cheung AN; Clement PB
    Am J Surg Pathol; 2009 Jul; 33(7):992-1005. PubMed ID: 19417585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fascin expression in uterine smooth muscle tumors.
    Kefeli M; Yildiz L; Kaya FC; Aydin O; Kandemir B
    Int J Gynecol Pathol; 2009 Jul; 28(4):328-33. PubMed ID: 19483633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EMMPRIN (CD147) Expression in Smooth Muscle Tumors of the Uterus.
    Kefeli M; Yildiz L; Gun S; Ozen FZ; Karagoz F
    Int J Gynecol Pathol; 2016 Jan; 35(1):1-7. PubMed ID: 26352545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of MCM2 With Ki67 and p16 Immunohistochemistry Can Distinguish Uterine Leiomyosarcomas.
    Keyhanian K; Lage JM; Chernetsova E; Sekhon H; Eslami Z; Islam S
    Int J Gynecol Pathol; 2020 Jul; 39(4):354-361. PubMed ID: 32515921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis in the diagnosis of uterine myometrial smooth muscle tumors.
    Stănescu AD; Nistor E; Sajin M; Stepan AE
    Rom J Morphol Embryol; 2014; 55(3 Suppl):1129-36. PubMed ID: 25607395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD56 is Expressed in Uterine Smooth Muscle Tumors.
    Karpathiou G; Chauleur C; Papoudou-Bai A; Dagher S; Peoc'h M
    Int J Gynecol Pathol; 2021 Jul; 40(4):315-323. PubMed ID: 32897962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comments on a better understanding of smooth muscle neoplasms in the uterus].
    Liu T
    Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):259-62. PubMed ID: 9388866
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions.
    Quade BJ
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):35-42. PubMed ID: 7742513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of smooth muscle tumors of the uterine corpus.
    Benda JA
    Clin Obstet Gynecol; 2001 Jun; 44(2):350-63. PubMed ID: 11344998
    [No Abstract]   [Full Text] [Related]  

  • 17. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
    Ip PP; Tse KY; Tam KF
    Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD147 expression in uterine smooth muscle tumors, and its potential role as a diagnostic and prognostic marker in patients with leiomyosarcoma.
    Ozler A; Evsen MS; Turgut A; Sak ME; Tunc SY; Agacayak E; Alabalik U; Basaranoglu S; Keles AN; Gul T
    J Exp Ther Oncol; 2014; 10(4):325-30. PubMed ID: 25509988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in the pathology of uterine smooth muscle neoplasms].
    Zhang J
    Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):313-6. PubMed ID: 9388879
    [No Abstract]   [Full Text] [Related]  

  • 20. Unusual types of smooth muscle tumors of uterine corpus: case reports and literature review.
    Makharoblidze E; Goishvili N; Mchedlishvili M; Khakhutaishvili I; Jangavadze M
    Georgian Med News; 2013 Mar; (216):7-11. PubMed ID: 23567300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.